A Phase I/II, Open-Label, Multicenter Study to Investigate the Safety and Preliminary Efficacy of Nktr-214 in Combination with Pembrolizumab in Patients with Locally Advanced or Metastatic Solid Tumors
A Randomized Phase III Study of Ibrutinib plus Obinutuzumab versus Ibrutinib plus Venetoclax and Obinutuzumab in Untreated Older Patients /= 65 Years of Age with Chronic Lymphocytic Leukemia CLL
A Phase I/Ib, Open Label, First-In-Human Study, Dose Escalation And Expansion Study For The Evaluation Of Safety, Pharmacokinetics, Pharmacodynamics, And Anti-Tumor Activity Of SAR445877 Administered As Monotherapy Or In Combination With An Anti PD L1 Therapy In Adults With Advanced Solid Tumors The ?Study?
Randomized Phase II Trial of Fulvestrant or Exemestane With or Without Ribociclib After Progression on Anti-Estrogen Therapy Plus Cyclin-Dependent Kinase 4/6 Inhibition in Patients With Unresectable or Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer MAINTAIN